Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation

Nicotine and Tobacco Research

Volumn 16, Issue 10, 2014, Pages 1356-1364

  Caldwell, Brent O ^a   Adamson, Simon J ^b   Crane, Julian ^a  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE PATCH; PLACEBO; RAPID ACTING NICOTINE; UNCLASSIFIED DRUG; NICOTINE GUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; ORAL SPRAY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT DURATION; UPPER GASTROINTESTINAL SYMPTOM; ADOLESCENT; CLINICAL TRIAL; DRUG COMBINATION; DRUG THERAPY; EPIDEMIOLOGY; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; NEW ZEALAND; PROCEDURES; SMOKING; TIME; UTILIZATION; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; NICOTINE; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84911361086     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu084     Document Type: Article

References (26)

1. Aveyard, P., & West, R. (2007). Managing smoking cessation. British Medical Journal (Clinical Research Ed.), 335, 37- 40. doi:10.1136/bmj.39252.591806.47
2. Barnett, R., Pearce, J., & Moon, G. (2009). Community inequality and smoking cessation in New Zealand, 1981-2006. Social Science and Medicine, 68(5), 876-884. doi:10.1016/j. socscimed.2008.12.012
3. Benowitz, N. L., Jacob, I. P., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J.,.. Velicer, W. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149-159. doi:10.1080/14622200210123581
4. Blondal, T., Gudmundsson, L. J., Olafsdottir, I., Gustavsson, G., Westin, A., & Stapleton, J. (1999). Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow up. British Medical Journal (Clinical Research Ed.), 318, 285-289. Retrieved from http://www. bmj.com
5. Bolliger, C. T., Van Biljon, X., & Axelsson, A. (2007). A nicotine mouth spray for smoking cessation: A pilot study of preference, safety and efficacy. Respiration, 74, 196-201. doi:10.1159/000097136
6. Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J., & Walker, N. (2013). Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. doi:10.1016/S0140-6736(13)61534-2
7. Cappelleri, J. C., Bushmakin, A. G., Baker, C. L., Merikle, E., Olufade, A. O., & Gilbert, D. G. (2005). Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Current Medical Research and Opinion, 21, 749-760. Retrieved from http://search.proquest.com/ docview/207964457
8. Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, 7-16. doi:10.1080/14622200020032051
9. Croghan, G. A., Sloan, J. A., Croghan, I. T., Novotny, P., Hurt, R. D., DeKrey, W. L.,.. Loprinzi, C. (2003). Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine & Tobacco Research, 5, 181-187. doi:10.1080/1462220031000073252
10. Fu, S. S., Sherman, S. E., Yano, E. M., van Ryn, M., Lanto, A. B., Joseph, A. M., & Fu, S. S. (2005). Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. American Journal of Health Promotion, 20, 108-116. Retrieved from https:// www.healthpromotionjournal.com/
11. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
12. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25. doi:10.1093/ntr/5.1.13
13. Kraiczi, H., Hansson, A., & Perfekt, R. (2011). Single-dose pharmacokinetics of nicotine when given with a Novel mouth spray for nicotine replacement therapy. Nicotine & Tobacco Research, 13, 1176-1182. doi:10.1093/ntr/ntr139
14. McDermott, M. S., Beard, E., Brose, L. S., West, R., & McEwen, A. (2012). Factors associated with differences in quit rates between "specialist" and "community" stopsmoking practitioners in the English stop-smoking services. Nicotine & Tobacco Research, 15. doi:10.1093/ntr/nts262
15. McRobbie, H., Thornley, S., Bullen, C., Lin, R., Senior, H., Laugesen, M.,.. Hajek, P. (2010). A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction, 105, 1290-1298. doi:10.1111/j.1360-0443.2010.02950.x
16. Ministry of Health. (2010). Tobacco use in New Zealand: Key findings from the 2009 New Zealand Tobacco Use Survey. Retrieved from http://www.moh.govt.nz/
17. Moore, S. M., & Charvat, J. (2007). Promoting health behavior change using appreciative inquiry: moving from deficit models to affirmation models of care. Family and Community Health, 30(1 Suppl), S64-74. Retrieved from http://journals. lww.com/familyandcommunityhealth/
18. NZ Parliament. (2011). Government response to the report of the Maori Affairs Committee on its enquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Maori (Final Response). Retrieved from http://www.parliament. nz/
19. R Development Core Team. (2010). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from http:// www.R-project.org/
20. Salmond, C., Crampton, P., King, P., & Waldegrave, C. (2006). NZiDep: A New Zealand index of socioeconomic deprivation for individuals. Social Science and Medicine, 62, 1474- 1485. doi:10.1016/j.socscimed.2005.08.008
21. Shiffman, S., Rolf, C. N., Hellebusch, S. J., Jane Gorsline, Gorodetzky, C. W., Chiang, Y.-K.,.. Marino, M. E. D. (2002). Real-world efficacy of prescription and over the counter nicotine replacement therapy. Addiction, 97, 505- 516. doi:10.1046%2Fj.1360-0443.2002.00141.x
22. Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Reviews, 4. doi:10.1002/14651858.CD000146.pub3
23. The QuitGroup. (2009). New Quitline Service Evaluation- Longitudinal Survey: Results from three week and six month follow-up survey. Retrieved from http://www.quit.org.nz/
24. Thornley, S., Jackson, G., McRobbie, H., Sinclair, S., & Smith, J. (2010). Few smokers in South Auckland access subsidised nicotine replacement therapy. New Zealand Medical Journal, 123, 16-27. Retrieved from http://www.nzma.org. nz/journal/
25. Tonnesen, P., Lauri, H., Perfekt, R., Mann, K., & Batra, A. (2012). Efficacy of a nicotine mouth spray in smoking cessation: A randomised, double blind trial. European Respiratory Journal, 40, 548-554. doi: 10.1183/09031936.00155811
26. Watts, S., Noble, S., Smith, P., & Disco, M. (2002). First-line pharmacotherapy for tobacco use and dependence. Journal of the American Board of Family Practice, 15, 489-497. Retrieved from http://www.jabfm.org